S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling
Background Immunotherapies for malignant melanoma are challenged by the resistance developed in a significant proportion of patients. Myeloid-derived suppressor cells (MDSC), with their ability to inhibit antitumor T-cell responses, are a major contributor to immunosuppression and resistance to immu...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2024-09-01
|
| Seri Bilgileri: | Journal for ImmunoTherapy of Cancer |
| Online Erişim: | https://jitc.bmj.com/content/12/9/e009552.full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|